Loading organizations...
Toronto Innovation Acceleration Partners (TIAP) is a venture builder, commercializing early-stage health science technologies from its academic members. It identifies, funds, and develops innovations across therapeutics, medical devices, and digital health. TIAP collaborates with inventors, leveraging industry advisors and co-investment to advance promising intellectual property into viable Canadian companies.
Established in 2008, TIAP was founded as a member-supported, not-for-profit organization. It addressed the imperative to commercialize innovative research from Toronto's top universities, hospitals, and research institutes. The founding insight focused on translating academic discoveries into impactful health solutions, creating a structured pathway for scientific breakthroughs to market.
TIAP’s primary collaborators are academic member institutions and their inventors, contributing foundational research. Developed innovations ultimately benefit patients with novel solutions. TIAP’s mission involves partnering with members, industry, and investors to transform health science innovation into successful Canadian ventures, aspiring to significantly impact human health by bringing these advancements to life.
Key people at Toronto Innovation Acceleration Partners.
Key people at Toronto Innovation Acceleration Partners.
Toronto Innovation Acceleration Partners has 2 tracked investments across 2 companies. The latest tracked deal is $3.2M Seed in HDAX Therapeutics in September 2024.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Sep 5, 2024 | HDAX Therapeutics | $3.2M Seed | David O'neill, Seedfolio, Toronto Innovation Acceleration Partners | — |
| Sep 21, 2021 | PhenoTips | $2.0M Seed | Gregory Stewart | Thin AIR Labs, Yorkville Partners |